Stocks and Investing Stocks and Investing
Tue, March 26, 2024

Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Increased Target to $190 on, Mar 26th, 2024


Published on 2024-10-28 09:54:59 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $180 to $190 on, Mar 26th, 2024.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Raghuram


  • Joel Beatty of "Baird" Initiated at Buy and Held Target at $108 on, Tuesday, March 19th, 2024
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $108 on, Tuesday, February 27th, 2024
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $103 on, Wednesday, February 21st, 2024
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $125 on, Wednesday, February 21st, 2024
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024

Contributing Sources